Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus PK in Primary Living Donor Liver Transplantation
NCT00909571Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus + Wuzhi capsule in Liver transplant rejection (2 arms), sponsored by Astellas Pharma. Primary endpoint: Assessment of pharmacokinetic parameters at Day 14. Started Apr 2009; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00909571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909571.